Back to School TB Screening: What Practitioners and Families Need to Know
LTBI is defined as infection with the tubercle bacilli without signs and symptoms or radiographic evidence of tuberculosis (TB) disease. Because LTBI is the precursor to TB disease, the early identification of children infected with the M.tuberculosis bacillus is a critical factor in preventing morbidity and mortality in the pediatric population. Equally important is the treatment of these children and a plan to ensure treatment completion. (Management of Latent Tuberculosis Infection In Children and Adolescents: A Guide for the Primary Care Provider: 2009 www.umdnj.edu/globaltb/products).
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hours, of which 0 is pharmacology content.
This course was supported by an educational grant from QIAGEN.
Copyright 2014 © by National Association of Pediatric Nurse Practitioners (NAPNAP).
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: firstname.lastname@example.org.
Pediatric-focused advanced practice registered nurses.
1. Apply risk-based American Academy of Pediatrics (AAP) guidance when screening school children for Tuberculosis.
2. Review CDC and AAP recommendations on use of tuberculin skin test and interferon-Gamma Release Assays (IGRA) in children.
3. Describe the pros and cons of using the tuberculin skin test (TST) or TB blood test in testing children going back to school.
Scott Lindquist, MD, MPH
Kim Fields, RN, MSN
Scott Lindquist is on the speaker's bureau for QIAGEN.
Kim Field has no relevant financial relationships to disclose.
- 1.00 Contact hours